Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

In the media

NSAIDS and risk of heart attack

10 May 2017: Sotiris Antoniou, spokesperson for the Royal Pharmaceutical Society (RPS) on cardiovascular medicine, spoke to the Daily Express about the link between NSAIDs and the risk of heart attack. The article was published in response to a systematic review and meta-analysis in The BMJ, which reported a raised risk of heart attack in when taking non-steroidal anti-inflammatory drugs, even for short durations.

“We now know all NSAIDs have the potential to increase the risk of having a heart attack,” Antoniou said.

“This paper suggests the larger the dose and the longer duration is associated with greater risk of harm. “If you have any doubts or questions seek advice from a pharmacist or doctor. It’s a good rule of thumb with any painkiller to take the lowest dose that’s effective for the shortest possible time.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202818

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.